IRIS - Res&Arch Institutional Research Information System - Research & Archive

LAZZERI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.087
EU - Europa 3.725
AS - Asia 2.891
SA - Sud America 547
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 6
Totale 11.328
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.952
SG - Singapore 1.183
IT - Italia 897
UA - Ucraina 645
IE - Irlanda 500
HK - Hong Kong 481
SE - Svezia 453
BR - Brasile 429
RU - Federazione Russa 408
CN - Cina 373
VN - Vietnam 368
DE - Germania 197
FR - Francia 165
FI - Finlandia 160
KR - Corea 160
GB - Regno Unito 89
CA - Canada 84
IN - India 63
TR - Turchia 50
AR - Argentina 43
BD - Bangladesh 41
BE - Belgio 33
CH - Svizzera 32
PL - Polonia 31
NL - Olanda 29
AT - Austria 27
MX - Messico 23
CO - Colombia 22
UZ - Uzbekistan 22
PK - Pakistan 21
IQ - Iraq 20
JP - Giappone 17
ZA - Sudafrica 16
ES - Italia 15
SA - Arabia Saudita 15
ID - Indonesia 13
VE - Venezuela 12
CL - Cile 11
EC - Ecuador 10
LB - Libano 10
MA - Marocco 9
TN - Tunisia 9
CZ - Repubblica Ceca 8
PY - Paraguay 8
EG - Egitto 7
EU - Europa 7
PH - Filippine 7
IR - Iran 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AU - Australia 5
JO - Giordania 5
RO - Romania 5
DZ - Algeria 4
GR - Grecia 4
KE - Kenya 4
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
JM - Giamaica 3
LT - Lituania 3
NP - Nepal 3
PR - Porto Rico 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BZ - Belize 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
LY - Libia 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GA - Gabon 1
GM - Gambi 1
GN - Guinea 1
GY - Guiana 1
HR - Croazia 1
Totale 11.307
Salva come PNG Salva come JPEG
Città #
Singapore 819
Chandler 614
Dublin 500
Hong Kong 475
Jacksonville 315
San Mateo 304
San Jose 250
Dong Ket 237
Ashburn 219
Boardman 186
Seoul 160
Santa Clara 151
Medford 127
Moscow 126
Princeton 126
Lauterbourg 106
Wilmington 101
Altamura 88
Beijing 81
Perugia 78
Des Moines 72
Lawrence 71
Andover 68
Ann Arbor 68
Rome 57
Ottawa 51
Piscataway 46
Shanghai 43
Los Angeles 42
Saint Petersburg 42
Milan 41
New York 41
Ho Chi Minh City 39
São Paulo 39
Munich 35
Brussels 33
Hanoi 33
Izmir 26
Norwalk 25
Orem 25
Helsinki 21
The Dalles 21
Frankfurt am Main 18
Vienna 18
Warsaw 18
Falls Church 17
Tokyo 17
San Paolo di Civitate 16
Woodbridge 15
Chennai 13
Redwood City 13
Rio de Janeiro 13
Tashkent 13
Florence 12
Montreal 12
Turku 12
Brooklyn 11
Naples 11
San Francisco 11
Atlanta 10
Council Bluffs 10
Dallas 10
Houston 10
Baghdad 9
Bologna 9
Johannesburg 9
Manchester 9
Ribeirão Preto 9
Charlotte 8
Chicago 8
Dhaka 8
Istanbul 8
Riyadh 8
Terni 8
Belo Horizonte 7
Da Nang 7
Den Haag 7
Islamabad 7
Medellín 7
New Delhi 7
Stockholm 7
West Jordan 7
Amsterdam 6
Brasília 6
Buenos Aires 6
Cagliari 6
Caracas 6
Columbus 6
Lahore 6
London 6
Padova 6
Phoenix 6
Redmond 6
Toronto 6
Turin 6
Brescia 5
Castrovillari 5
Changsha 5
City of London 5
Hefei 5
Totale 6.534
Salva come PNG Salva come JPEG
Nome #
Ruolo della colposospensione sec.Burch associata a ricostruzione integrale per via addominale in pazienti continenti e incontinenti affette da prolasso urogenitale avanzato. Rivalutazione a lungo termine di 2 studi clinici randomizzati 398
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 392
ABDOMINAL VS LAPAROSCOPIC SACROPEXY: SUBGROUP ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL 270
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 260
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 238
Valutazione dell’attività sessuale mediante questionario FSFI in pazienti sottoposte a sling medio-uretrale: studio multicentrico 168
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 158
Abdominal pelvic floor reconstruction with uterus preservation 139
Evaluation of Prostate-Specific Antigen Isoform p2PSA and Its Derivates, %p2PSA, Prostate Health Index and Prostate Dimension-Adjusted Related Index in the Detection of Prostate Cancer at First Biopsy: An Exploratory, Prospective Study. 137
Performance of incontinence impact questionnaire (IIQ) in italian population according to educational status 137
Abdominal integral pelvic reconstruction plus or minus Burch colposuspension in the treatment of severe uro-genital prolapse associated to urinary incontinence. A RCT with a mid-term follow up 135
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair? A case control study 127
Long-term outcome of anti-incontinence procedure during Pelvic Organ Prolapse repair in patients with or without urinary incontinence: results from two randomized surgical trials 125
Abdominal vs laparoscopic sacrocolpopexy: subgroup analysis of a prospective randomized trial 125
Master di II livello in uroginecologia: quali i risultati chirurgici 124
Uterovaginal prolapse in a woman desiring uterus preservation. Case Presentation with Expert discussion 124
Prulifloxacin vs Phosphomycin: Prophylaxis in patients with recurrent UTI. Preliminary results of a randomized multi-centre study 122
Valutazione dell’attività sessuale pre e post operatoria mediante questionario FSFI in pazienti sottoposti a sling medio uretrale 121
Management of healing abnormalities after abdominal pelvic organ prolapse repair 112
Il ruolo del MUCP e del VLPP preoperatori nel predirre i risultati delle pazienti sottoposte a TOT 110
Long-Term follow-up uterus sparing surgery for pelvic organ prolapse (POP) 109
Overactive bladder symptoms (OAB) and detrusor overactivity (DO) in patients with posterior vault prolapse: Prevalence and its changes after POP repair 108
POLYVINYLIDENFLUORID (PVDF) AND POLYPROPYLENE MESH FOR SACROCOLPOPEXY: A COMPARATIVE STUDY 106
Retropubic versus transobturator mid-urethral slings: in a randomised controlled trial pre-operative VLPP may not predict mid-term outcome 104
Editorial comment on: Cizolirtine Citrate is safe and effective for treating Urinary Incontinence secondary to overactive bladder: a Phase 2 proof-of-concept study 103
Uro-genital prolapse surgery: update on post-operative urinary incontinence 103
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 102
Profilassi con Plurifloxacina vs Fosfomicina in pawienti affette da cistiti ricorrenti. Risultati preliminari di uno studio randomizzato 98
Risultati chirurgici nelle donne in età avanzata 98
The management of healing abnormalities after abdominal pelvic organ prolapse repair 96
Surgical outcome during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair: case control study 96
Female sexual function evaluation in patients who underwent integral pelvic floor reconstructive surgery 96
Burch colposuspension does not provide any additional benefit to pelvic organ prolapse repair in patients with urinary incontinence: A randomized surgical trial 96
Urinary Tract Infections in Women With Type 1 Diabetes Mellitus: Survey of Female Participants in the Epidemiology of Diabetes Interventions and Complications Study Cohort COMMENT 95
Chirurgia del prolasso con preservazione dell’utero: risultati a lungo termine 95
Uterus sparing surgery: A paradigm shift. Effectively managing POP includes prioritising patient’s wish 94
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent POP (Pelvic Organ Prolapse) repair 94
Prevalence of sexual activity in waiting list women for pelvic organ prolapse and/or urinary incontinence surgery: a cross sectional survey 94
Cambiamenti della funzione sessuale nelle pazienti con sling medio-uretrali per incontinenza urinaria da stress 93
Patients of surgical educational course may have a poorer outcome for pelvic organ prolapse repair and higher complication rate: a case-control study in urogynecology 92
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent pelvic organ prolapse repair 89
Deterioration of continence after TOT when the follow-up is extended: results from a randomised controlled study 89
Laparoscopic Versus Abdominal Sacrocolpopexy: A Randomized, Controlled Trial 89
Preoperative MUCP and VLPP failed to predict outcome in patients who underwent transobturator mid-urethral slings 88
FSFI: modificazioni dell’attività sessuale pre e post-intervento nelle pazienti sottoposte a chirurgia ricostruttiva del pavimento pelvico 88
Impact of a teaching program on outcome quality of white light transurethral resection for bladder tumor: A cohort study 88
Open-Label, Longitudinal Study of Tamsulosin for Functional Bladder Outlet Obstruction in Women 87
Changes in female sexual function after pelvic organ prolapse repair: role of hysterectomy 87
Preoperative urinary incontinence is the main risk factor for post operative incontinence in women who underwent pelvic organ prolapse repair 86
Profilassi in pazienti affette da cistiti ricorrenti: risultati preliminari di uno studio randomizzato multicentrico; prulifloxacina vs fosfomicina 85
Prolasso di volta a prevalenza posteriore: relazione con i sintomi da vescica iperattiva e con l’iperattività detrusoriale prima e dopo intervento chirurgico 85
Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study 85
Colposacropessia laparoscopica versus Colposacropessia addominale: subanalisi di uno studio randomizzato 85
Managing Mesh Erosion after Abdominal Pelvic Organ Prolapse Repair: Ten Years Experience in a Single Center 84
IMPACT OF MID URETHRAL SLING ON FEMALE SEXUAL FUNCTION. A PROSPECTIVE MULTICENTRE STUDY 84
Uterus preservation in pelvic organ prolapse surgery 82
The Incontinence Impact Questionnaire: Results in an Italian Female Population Stratified by Educational Status 82
Pre-operative VLPP may not predict the mid-term out come of mid-urethral slings. A retrospective analysis from a randomized controller trial of TVT versus TOT mid-urethral slings 82
Fattori di rischio per l’incontinenza urinaria post-operatoria in pazienti affette da prolasso severo e sottoposte a ricostruzione integrale del pavimento pelvico 82
Urodynamics for Pelvic Organ Prolapse Surgery: "Par for the Course" 82
Sexual changes after pop repair. Is hysterectomy a key element? 81
Managing complications after midurethral sling for stress urinary incontinence 80
Burch colposuspension and pelvic organ prolapse repair in patients with and without urinary incontinence: results from two randomised surgical trials 80
Are We in a Robotic Surgical Bubble Market? 80
Treatment of severe uro-genital prolapse associated with urinary incontinence by means of abdominal integral pelvic floor reconstruction with or without Burch colposuspension. A RCT with a mid-term follow-up 80
Preoperative MUCP and VLPP may not predict mid-term outcome in patients who underwent transobturator mid-urethral slings (TOT) 80
Lean Mean Research: The 21st Century Challenge for Urology 79
Long-term outcome of anti-incontinence procedure during pelvic organ prolapse repair in patients with and without urinary incontinence: results from two randomised controlled trials 78
Five-year outcome of uterus sparing surgery for pelvic organ prolapse repair: a single-center experience 78
Cost-utility rations (CURs) and different levels of effectiveness in urinary incontinence (UI) management 78
Uterus sparing surgery for pelvic organ prolapse (POP): long term results 77
Sexual activity before and after mid urethral sling. A prospective multicentre study 77
Sexual changes after POP repair. Is hysterectomy a key element? 77
Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium Hyaluronate-chondroitin sulphate (Ialuril®). 77
Is the tension-free vaginal tape procedure for stress urinary incontinence safe and effective in the long term? 76
Preoperative Valsava Leak Point Pressure May Not Predict Outcome of Mid-Urethral Slings. Analysis from a Randomized Controlled Trial of Retropubic versus Transobturator Mid-Urethral Slings 75
Posterior vault prolapse and overactive bladder symptoms (OAB): changes after POP repair 75
The Challenge of the Overactive Bladder: From Laboratory to New Drugs 75
Surgical outcomes in aging women 74
Hysterectomy and stress urinary incontinence. 74
Hydronephrosis and Pelvic Organ Prolapse 72
Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial. 72
Long-term Efficacy of the Transobturator and Retropubic Midurethral Slings for Stress Urinary Incontinence: Single-center Update from a Randomized Controlled Trial. 72
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (sui) and pelvic organ prolapse (pop) repair? A case control study 70
Intravesical administration of combined hyaluronic acid and chondroitin sulphate vs standard of care for the treatment of female recurrent urinary tract infections (RUTIs): What did we learn from a multicentre European real life setting case-control study? 70
Editorial comment on: Tension free vaginale tape in the management of recurrent urodynamics stress incontinence after previous failed midurethral tape 70
Il trattamento delle complicanze dopo chirurgia addominale per il prolasso degli organi pelvici 68
Il ruolo degli ultrasuoni nella definizione del deficit sfinterico uretrale 68
Long-term follow-up of uterus sparing surgery for pelvic organ prolapse (POP) 68
Pelvic Organ Prolapse Repair With and Without Prophylactic Concomitant Burch Colposuspension in Continent Women: A Randomized, Controlled Trial With 8-Year Followup 68
Cost-Utility Ratios (CURS) and different levels of effectiveness in urinary incontinence (UI) management 67
Iatrogenic Trapped Penis in Adults: New, Simple 2-Stage Repair 66
Pelvic organ prolapse and lower urinary tract symptoms: experience from a high-volume uro-gynecologic center 66
Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence 65
Long-term efficacy of the trans-obturator and retropubic mid-urethral slings for stress urinary incontinence: update from a randomized clinical trial 64
Safety and efficacy of Perigee TM system – AMS for the treatment of women with symptomatic anterior compartment prolapse: observational descriptive analysis in a high volume center 63
L’analisi costo-utilità nel trattamento dell’incontinenza urinaria femminile 63
The role of ultrasound in the definition of female urethral sphincter deficiency: one tertiary centre experience 62
Morphological Changes of Bladder Mucosa in Patients Who Underwent Instillation with Combined Sodium Hyaluronic Acid-Chondroitin Sulphate (Ialuril®) 62
SACROCOLPOPEXY FOR POST-HYSTERECTOMY VAGINAL VAULT PROLAPSE: LONG TERM FOLLOW-UP 62
Totale 10.092
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021428 0 0 0 0 0 0 0 0 0 38 107 283
2021/20221.144 21 273 25 76 47 12 12 286 11 28 146 207
2022/20231.923 179 326 36 137 134 227 5 121 664 7 61 26
2023/2024952 34 83 45 23 16 15 295 81 117 22 127 94
2024/20251.608 79 173 86 48 260 64 15 114 315 108 204 142
2025/20263.036 265 214 139 435 365 272 556 126 369 295 0 0
Totale 11.548